Glycosyltransferases as Markers for Early Tumorigenesis

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Andergassen, Ulrich ^a   Liesche, Friederike ^a   Kölbl, Alexandra C ^a   Ilmer, Matthias ^b   Hutter, Stefan ^a   Friese, Klaus ^a   Jeschke, Udo ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(ALPHA N ACETYL NEURAMINYL 2,3 BETA GALACTOSYL 1,3) N ACETYLGALACTOSAMINE ALPHA 2,6 SIALYLTRANSFERASE 1; BETA 1,6 N ACETYLGLUCOSAMINYLTRANSFERASE 2; GLYCOSYLTRANSFERASE; GLYCOSYLTRANSFERASES N ACETYLGALACTOSAMINYLTRANSFERASE 6; UNCLASSIFIED DRUG; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATIONAL STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVESTIGATIVE PROCEDURES; MAJOR CLINICAL STUDY; MICROSCOPY; TUMOR VOLUME; BREAST TUMOR; ENZYMOLOGY; FEMALE; KAPLAN MEIER METHOD; METABOLISM; PATHOLOGY;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; CARCINOGENESIS; FEMALE; GLYCOSYLTRANSFERASES; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE;

EID: 84934312278     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/792672     Document Type: Article

References (50)

1. T. P. Skelton, C. Zeng, A. Nocks, and I. Stamenkovic, "Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan", The Journal of Cell Biology, vol. 140, no. 2, pp. 431-446, 1998.
2. M. S. Diamond, D. E. Staunton, S. D. Marlin, and T. A. Springer, "Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation", Cell, vol. 65, no. 6, pp. 961-971, 1991.
3. L. M. McEvoy, H. Sun, J. G. Frelinger, and E. C. Butcher, "Anti-CD43 inhibition of T cell homing", The Journal of Experimental Medicine, vol. 185, no. 8, pp. 1493-1498, 1997.
4. J. W. Dennis, M. Granovsky, and C. E. Warren, "Glycoprotein glycosylation and cancer progression", Biochimica et Biophysica Acta: General Subjects, vol. 1473, no. 1, pp. 21-34, 1999.
5. P. M. Rudd, T. Elliott, P. Cresswell, I. A. Wilson, and R. A. Dwek, "Glycosylation and the immune system", Science, vol. 291, no. 5512, pp. 2370-2376, 2001.
6. H. Clausen and E. P. Bennett, "A family of UDP-GalNAc: polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation", Glycobiology, vol. 6, no. 6, pp. 635-646, 1996.
7. F. L. Homa, T. Hollander, D. J. Lehman, D. R. Thomsen, and A. P. Elhammer, "Isolation and expression of a cDNA clone encoding a bovine UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase", The Journal of Biological Chemistry, vol. 268, no. 17, pp. 12609-12616, 1993.
8. K. G. Ten Hagen, T. A. Fritz, and L. A. Tabak, "All in the family: the UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases", Glycobiology, vol. 13, no. 1, pp. 1R-16R, 2003.
9. J. Gomes, N. T. Marcos, N. Berois et al., "Expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma", Journal of Histochemistry and Cytochemistry, vol. 57, no. 1, pp. 79-86, 2009.
10. U. Mandel, H. Hassan, M. H. Therkildsen et al., "Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNActransferase family", Glycobiology, vol. 9, no. 1, pp. 43-52, 1999.
11. S.-I. Hakomori, "Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives", Cancer Research, vol. 45, no. 6, pp. 2405-2414, 1985.
12. S.-I. Hakomori, "Tumor malignancy defined by aberrant glycosylation and sphingo (glyco) lipid metabolism", Cancer Research, vol. 56, no. 23, pp. 5309-5318, 1996.
13. T. Feizi, "Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are oncodevelopmental antigens", Nature, vol. 314, no. 6006, pp. 53-57, 1985.
14. I. Brockhausen, "Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions", EMBO Reports, vol. 7, no. 6, pp. 599-604, 2006.
15. S. Hakomori, "Carbohydrate-to-carbohydrate interaction in basic cell biology: a brief overview", Archives of Biochemistry and Biophysics, vol. 426, no. 2, pp. 173-181, 2004.
16. S. Julien, E. Adriaenssens, K. Ottenberg et al., "ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity", Glycobiology, vol. 16, no. 1, pp. 54-64, 2006.
17. S. Julien, C. Lagadec, M.-A. Krzewinski-Recchi, G. Courtand, X. Le Bourhis, and P. Delannoy, "Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration", Breast Cancer Research and Tre atment, vol. 90, no. 1, pp. 77-84, 2005.
18. S. E. Baldus, K. Engelmann, and F.-G. Hanisch, "MUC1 and the MUCs: a family of human mucins with impact in cancer biology", Critical Reviews in Clinical Laboratory Sciences, vol. 41, no. 2, pp. 189-231, 2004.
19. P. R. Crocker, "Siglecs in innate immunity", Current Opinion in Pharmacology, vol. 5, no. 4, pp. 431-437, 2005.
20. M. Gerloni, P. Castiglioni, and M. Zanetti, "The cooperation between two CD4 T cells induces tumor protective immunity in MUC.1 transgenic mice", The Journal of Immunology, vol. 175, no. 10, pp. 6551-6559, 2005.
21. T. M. Onami, L. E. Harrington, M. A. Williams et al., "Dynamic regulation of T cell immunity by CD43", Journal of Immunology, vol. 168, no. 12, pp. 6022-6031, 2002.
22. A. Varki and T. Angata, "Siglecs-the major subfamily of I-type lectins", Glycobiology, vol. 16, no. 1, pp. 1R-27R, 2006.
23. A. Cazet, S. Julien, M. Bobowski, J. Burchell, and P. Delannoy, "Tumour-associated carbohydrate antigens in breast cancer", Breast Cancer Research, vol. 12, article 204, 2010.
24. E. Dabelsteen, "Cell surface carbohydrates as prognostic markers in human carcinomas", The Journal of Pathology, vol. 179, no. 4, pp. 358-369, 1996.
25. M. A. Hollingsworth and B. J. Swanson, "Mucins in cancer: protection and control of the cell surface", Nature Reviews Cancer, vol. 4, no. 1, pp. 45-60, 2004.
26. Y. J. Kim and A. Varki, "Perspectives on the significance of altered glycosylation of glycoproteins in cancer", Glycoconjugate Journal, vol. 14, no. 5, pp. 569-576, 1997.
27. D. W. Miles, L. C. Happerfield, P. Smith et al., "Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in nodepositive breast cancer", British Journal of Cancer, vol. 70, no. 6, pp. 1272-1275, 1994.
28. J. M. Burchell, A. Mungul, and J. Taylor-Papadimitriou, "O-linked glycosylation in the mammary gland: changes that occur during malignancy", Journal of Mammary Gland Biology and Neoplasia, vol. 6, no. 3, pp. 355-364, 2001.
29. K. O. Lloyd, J. Burchell, V. Kudryashov, B. W. T. Yin, and J. Taylor-Papadimitriou, "Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines: demonstration of simpler and fewer glycan chains in tumor cells", The Journal of Biological Chemistry, vol. 271, no. 52, pp. 33325-33334, 1996.
30. P. Buckhaults, L. Chen, N. Fregien, and M. Pierce, "Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene", The Journal of Biological Chemistry, vol. 272, no. 31, pp. 19575-19581, 1997.
31. N. Le Marer, V. Laudet, E. C. Svensson et al., "The c-Ha-ras oncogene induces increased expression of β-galactoside α-2, 6-sialyltransferase in rat fibroblast (FR3T3) cells", Glycobiology, vol. 2, no. 1, pp. 49-56, 1992.
32. D. H. Joziasse, "Mammalian glycosyltransferases: genomic organization and protein structure", Glycobiology, vol. 2, no. 4, pp. 271-277, 1992.
33. J. C. Paulson, J. Weinstein, E. L. Ujita, K. J. Riggs, and P. H. Lai, "The membrane-binding domain of a rat liver Golgi sialyltransferase", Biochemical Society Transactions, vol. 15, no. 4, pp. 618-620, 1987.
34. E. P. Bennett, H. Hassan, U. Mandel et al., "Cloning and characterization of a close homologue of human UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy", The Journal of Biological Chemistry, vol. 274, no. 36, pp. 25362-25370, 1999.
35. S. A. Brooks, T. M. Carter, E. P. Bennett, H. Clausen, and U. Mandel, "Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer", Acta Histochemica, vol. 109, no. 4, pp. 273-284, 2007.
36. T. Freire, N. Berois, C. Sóñora, M. Varangot, E. Barrios, and E. Osinaga, "UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 6 (ppGalNAc-T6) mRNA as a potential new marker for detection of bone marrowdisseminated breast cancer cells", International Journal of Cancer, vol. 119, no. 6, pp. 1383-1388, 2006.
37. M. Nomoto, H. Izumi, T. Ise et al., "Structural basis for the regulation of UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 gene expression in adenocarcinoma cells", Cancer Research, vol. 59, no. 24, pp. 6214-6222, 1999.
38. H. H. Wandall, S. Dabelsteen, J. A. Sørensen, A. Krogdahl, U. Mandel, and E. Dabelsteen, "Molecular basis for the presence of glycosylated onco-foetal fibronectin in oral carcinomas: the production of glycosylated onco-foetal fibronectin by carcinoma cells", Oral Oncology, vol. 43, no. 3, pp. 301-309, 2007.
39. J. C. Paulson and K. J. Colley, "Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation", The Journal of Biological Chemistry, vol. 264, no. 30, pp. 17615-17618, 1989.
40. M. Hebbar, M.-A. Krzewinski-Recchi, L. Hornez et al., "Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patients", International Journal of Biological Markers, vol. 18, no. 2, pp. 116-122, 2003.
41. M.-A. Recchi, M. Hebbar, L. Hornez, A. Harduin-Lepers, J.-P. Peyrat, and P. Delannoy, "Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer", Cancer Research, vol. 58, no. 18, pp. 4066-4070, 1998.
42. J.-H. Park, T. Nishidate, K. Kijima et al., "Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis", Cancer Research, vol. 70, no. 7, pp. 2759-2769, 2010.
43. N. Berois, D. Mazal, L. Ubillos et al., "UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker", Journal of Histochemistry & Cytochemistry, vol. 54, no. 3, pp. 317-328, 2006.
44. H. Zhang, F. Meng, S. Wu et al., "Engagement of I-branching β-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-β signaling", Cancer Research, vol. 71, no. 14, pp. 4846-4856, 2011.
45. C.-P. Chuu, R.-Y. Chen, J. L. Barkinge, M. F. Ciaccio, and R. B. Jones, "Systems-level analysis of ErbB4 signaling in breast cancer: a laboratory to clinical perspective", Molecular Cancer Research, vol. 6, no. 6, pp. 885-891, 2008.
46. W. Remmele and H. E. Stegner, "Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue", Pathologe, vol. 8, no. 3, pp. 138-140, 1987.
47. T. Holbro and N. E. Hynes, "ErbB receptors: directing key signaling networks throughout life", Annual Review of Pharmacology and Toxicology, vol. 44, pp. 195-217, 2004.
48. C. B. Madsen, C. Petersen, K. Lavrsen et al., "Cancer associated aberrant protein O-glycosylation can modify antigen processing and immune response", PLoS ONE, vol. 7, no. 11, Article ID e50139, 2012.
49. T. Y. Kew, J. A. Bell, S. E. Pinder et al., "c-erbB-4 protein expression in human breast cancer", British Journal of Cancer, vol. 82, no. 6, pp. 1163-1170, 2000.
50. M. Hollmén, P. Liu, K. Kurppa et al., "Proteolytic processing of ErbB4 in breast cancer", PLoS ONE, vol. 7, no. 6, Article ID e39413, 2012.